Home | Partnership | Careers | Contact Us | Location Map | Sign In
   
 
   
 
 
 

 
 
 
Home >> Media Zone >Press Releases > News @ Panacea Biotec
E-mail this page Print this page
Title : Panacea Biotec announces ANDA approval for US Market and LTA & Award from UN Agencies for Supply of Pentavalent Vaccine (Easyfive-TT)
Date : January 18, 2017
Title : Panacea Biotec Ensures Increased availability of Life Saving Drug Cilamin 250 (D-Penicillamine IP 250mg) Capsules for Treatment of Wilson's disease in India
Date : January 3, 2017
 
Title : Panacea Biotec Introduces fully liquid Tetravalent Vaccine Easyfour-TT against DTP and Hib
Date : December 26, 2016
 
Title : Panacea Biotec announces Receipt of Establishment Inspection Report (EIR) from USFDA for its pharmaceutical facilities at Baddi
Date : December 21, 2016
 
Title : CII National Conference on “Vaccine Industry in India: Current Status and Future Prospects”, Hotel Hayat Regency, New Delhi
Date : November 10, 2016
 
Title : Panacea Biotec Ensures limited availability of Life Saving Drug Cilamin 250 Capsule (D-Penicillamine IP 250 mg)
Date : September 28, 2016
 
Title : Panacea Biotec Launches - TENEPAN, A Cost Effective product for the treatment of Type 2 Diabetes Mellitus (T2DM)
Date : June 28, 2016
 
Title : Panacea Biotec Receives Prestigious Intellectual Property & Science Award “Top 50 Indian Innovators 2015
Date : March 30, 2016
 
Title : Panacea Biotec Launches - CABAPAN, A cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)
Date : March 28, 2016